G-protein-coupled receptors (GPCRs) comprise the largest family of membrane proteins in the human genome and mediate cellular responses to an extensive array of hormones, neurotransmitters and sensory stimuli. Although some crystal structures have been determined for GPCRs, most are for modified forms, showing little basal activity, and are bound to inverse agonists or antagonists. Consequently, these structures correspond to receptors in their inactive states. The visual pigment rhodopsin is the only GPCR for which structures exist that are thought to be in the active state 1, 2 . However, these structures are for the apoprotein, or opsin, form that does not contain the agonist all-trans retinal. Here we present a crystal structure at a resolution of 3 Å for the constitutively active rhodopsin mutant Glu 113 Gln [3] [4] [5] in complex with a peptide derived from the carboxy terminus of the a-subunit of the G protein transducin. The protein is in an active conformation that retains retinal in the binding pocket after photoactivation.
Comparison with the structure of ground-state rhodopsin 6 suggests how translocation of the retinal b-ionone ring leads to a rotation of transmembrane helix 6, which is the critical conformational change on activation 7 . A key feature of this conformational change is a reorganization of water-mediated hydrogen-bond networks between the retinal-binding pocket and three of the most conserved GPCR sequence motifs. We thus show how an agonist ligand can activate its GPCR.
In the dark, rhodopsin contains a covalently bound 11-cis retinal chromophore that preferentially binds to the inactive state and therefore functions as an inverse agonist in the visual system. On exposure to light, the retinal isomerizes to the all-trans form, initiating a series of conformational changes leading to the transient signalling state metarhodopsin II.
Crystal structures of bovine rhodopsin have been determined for the inactive state of the native protein bound to 11-cis retinal and from crystals of the protein following photoisomerization of the chromophore to the all-trans form 8 . However, these structures represent early photointermediates in the activation pathway 9-11 that have not yet undergone the critical conformational alteration required for activation of the G protein.
Recently, two similar structures have been determined for the apoprotein form opsin 1, 2 . These are thought to represent activated forms of the receptor because one was determined for opsin bound to a peptide derived from the C-terminal tail of the a-subunit of the G protein transducin (the GaCT peptide) known to bind preferentially and stabilize the active intermediate metarhodopsin II 12 . Although the opsin structures have been of immense value, a complete understanding of the active state requires structures in which the all-trans retinal agonist is included in the ligand-binding pocket of the receptor.
We have obtained such a structure by crystallization of the Glu 113 Gln 3.28 mutant (superscripts denote Ballesteros-Weinstein general GPCR numbering 13 ) that drastically slows hydrolysis and dissociation of all-trans retinal from the photoactivated protein by a, 2F o 2 F c map (contoured at 1.5s) of the retinal-binding pocket. The retinal b-ionone ring is well resolved whereas the density of the polyene chain broadens towards the end facing Lys 296 7.43 . , as counterion to the protonated Schiff base, and Lys 296 7.43 is broken in the Glu 113 Gln/GaCT structure, removing the restraining TM3 and TM7 in the ground state neutralization of the retinal counterion 4 . Furthermore, the mutant shifts the classical metarhodopsin I/metarhodopsin II equilibrium towards active metarhodopsin II and maintains metarhodopsin III in an active conformation 14 . Finally, the opsin form of the Glu 113 Gln 3.28 mutant is constitutively active 5 , and addition of all-trans retinal to the apoprotein can activate the mutant to levels comparable to those of light-activated wild-type rhodopsin 4, 15 , essentially turning rhodopsin into a GPCR that is activated by diffusible agonists. However, the Glu 113 Gln 3.28 mutant is also significantly less stable than wild-type rhodopsin ( Supplementary Fig. 1 ), and for this reason we used the Glu 113 Gln mutation in the context of another rhodopsin mutant, Asn 2 Cys/Asp 282 Cys, which contains an engineered disulphide bond known to enhance thermal stability of the protein without affecting activity 14, 16 or structure 17 . The Glu 113 Gln/Asn 2 Cys/Asp 282 Cys triple mutant (henceforth referred to simply as the Glu 113 Gln 3.28 mutant) was reconstituted with 11-cis retinal during purification and, just before crystallization, was activated by selective illumination of protonated retinal in presence of the GaCT peptide. Crystals used for data collection had a faint yellow colour ( Supplementary Fig. 2 ) indicative of bound retinal.
The structure contains residues 1-326 of the mutant opsin and all eleven residues of the GaCT peptide, including the Lys 341 R Leu mutation introduced to increase affinity for the receptor 18 . In addition, clear electron density is observed for two partially ordered lipid molecules, one molecule of octylglucoside, several water molecules and, most strikingly, retinal within the ligand-binding pocket of the receptor. With the exception of the missing oligosaccharyl chain at position 2, the recombinantly produced protein contains all post-translational modifications observed with the native protein including acetylation of the amino terminus, palmitoylation of Cys residues at positions 322 and 323, and glycosylation of Asn at position 15. Finally, the engineered disulphide between Cys residues at positions 2 and 282 is clearly visible in the mutant.
The structure of the Glu 113 Gln/GaCT complex deviates significantly from the ground state of rhodopsin (Protein Data Bank ID, 1GZM 6 ), but has high similarity to the active-state structure of the opsin/GaCT complex (PDB ID, 3DQB
2 ), with respective Ca root mean squared deviations of 2.42 Å and 0.58 Å (Supplementary Fig. 3 ). The Glu 113 Gln/GaCT structure is also in excellent agreement with the results of high-resolution distance mapping using double electronelectron resonance (DEER) spectroscopy where pairs of nitroxide spin labels (in particular at positions 241 and 252) were used to quantify an outward movement of transmembrane helix 6 (TM6) by 5 Å that is critical to the activation process 7 (Supplementary Table 1 ). Other residues not showing significant change in the DEER experiments also do not show significant difference from ground-state rhodopsin in the Glu 113 Gln/GaCT structure.
On the basis of constitutive activity of the Glu 113 Gln 3.28 mutant, the presence of the GaCT peptide and the agreement with the results of DEER spectroscopy, we conclude that the structure of the Glu 113 Gln/ GaCT complex reported here is in fact that of the active state. Electron density for retinal (Fig. 1) is clearly observed in the general area where 11-cis retinal is found in ground-state rhodopsin. However, density for the nearby side chain of Lys 296 7.43 is weak, indicating that retinal is not bound to the protein covalently by a Schiff base, as in the ground state or metarhodopsin II. In addition, density for the b-ionone ring and most of the polyene chain is well defined but shows increasing disorder after position C9. We have modelled retinal in the all-trans conformation, but on the basis of occupancy refinement we estimate a 60:40 mixture of all-trans retinal and a mixed population. However, we cannot distinguish between a model based on a mixture of cis and trans isomers, catalysed for example by phosphatidylethanolamine lipids 19 or Lys 296 7.43 , and one based on a mixture of conformers arising from rotations about single bonds in the polyene chain or one with residual, covalently bound all-trans retinal contributing to the density.
Clearly, the structure represents an active conformation but is not identical to metarhodopsin II. We suspect that it probably corresponds to a trapped intermediate in which the retinal is either entering or exiting the ligand-binding pocket. It is well established that wild-type 
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opsin transiently activates as retinal enters the binding pocket but before a covalent bond to Lys 296 7.43 has been formed 20 , and that both all-trans and 11-cis retinol can act as potent partial agonists 21 . In this regard, the well-ordered ionone ring end of retinal and part of the polyene chain in the Glu 113 Gln/GaCT structure is probably in the same position that it occupies in metarhodopsin II. With respect to ground-state rhodopsin, the b-ionone ring is shifted by 4.3 Å (Fig. 1) and inserted in the cleft between TM5 (residues Met 207 5.42 , Phe 208 5.43 and Phe 212 5.47 ) and TM6 (residues Trp 265 6.48 , Ala 269 6.52 and Ala 272 6.55 ). This position is in agreement with two-dimensional dipolar-assisted rotational resonance NMR experiments on the retinal position in metarhodopsin II 22 . The transition from inactive to active states evident on comparison of the ground-state and active-state structures is accompanied by a global rearrangement of the helix bundle (Fig. 2) that shifts the cytoplasmic end of TM6 (and to a lesser extent TM5) away from the bundle core (TM1-4 and TM7). This shift is not achieved through a hinge movement but by a rotation of TM6 that leaves the shape of the helix intact. On the cytoplasmic side, the conformational change is amplified by the characteristic bend caused by Pro 267 6.50 , which is the most conserved residue in TM6 among GPCRs and part of the ubiquitous CWXP motif (where X denotes any amino acid). Pro 267 6 .50 is in close contact with water molecule 7, which is hydrogen-bonded to Cys 264 6.47 , Tyr 268
6.51 and Pro 291 7.38 , an arrangement similar to that observed in ground-state rhodopsin. This water is found also in structures of the b 1 -adrenergic 23 , b 2 -adrenergic 24 and adenosine receptors 25 , and probably forms an important architectural element in formation of the bend in TM6.
Trp 265 6 .48 of the CWXP motif is a highly conserved amino acid that is tightly packed against retinal in ground-state rhodopsin and has been identified as important for GPCR activation through early mutagenesis studies. Trp 265 6 .48 has a central role in the toggle-switch model for activation of GPCRs 26, 27 . Our structure places the indole group of Trp 265 6.48 3.6 Å away from its ground-state position as a consequence of rhodopsin activation. However, we do not observe the rotamer change that was originally proposed on the basis of computer simulations. Instead, Trp 265 6.48 follows the b-ionone ring, maintaining contact with the C18 methyl group. We suggest that the critical movement of TM6 stems from a motion of the b-ionone ring of retinal against TM6 just beneath the CWXP motif, while Trp 265 6 .48 is simultaneously released from its locked ground-state position.
Of special interest in the Glu 113 Gln/GaCT structure is a cluster of densities that indicate the presence of structural water molecules (Fig. 3) between some of the most conserved residues in GPCRs. Although modelling of water is difficult at resolutions around 3 Å , we are confident in their position because omission of water molecules during refinement resulted in clear difference peaks, presumably due to tight hydrogen bonding typical for structural water molecules in the interior of membrane proteins. Our interpretation is further strengthened by the presence of a similar water-mediated hydrogen-bond a, Our crystallographic data indicates water molecules that mediate interactions between the retinal-binding region and the GaCT-binding site. Omission of water molecules during simulated annealing results in strong electron density difference peaks (blue mesh, 2F o 2 F c map contoured at 2.0s; green mesh, F o 2 F c map contoured at 3.0s), demonstrating a high degree of local order. b, The retinal-binding pocket of ground-state rhodopsin is connected with Asn 302 7.49 of the NPXXY motif (blue) via water-mediated hydrogen-bond networks 6 . A region called the hydrophobic barrier (green) separates this network from the E(D)RY motif (pink) critical for G-protein activation. c, In the active Glu 113 Gln/GaCT structure, rotation of TM6 disrupts the watermediated link between Trp 265 6.48 and Ser 298 7.45 in TM7 and reorganizes the ground-state hydrogen-bond network. The hydrophobic barrier opens and Tyr 306 7 .53 of the NPXXY motif (blue) in TM7 and Tyr 223 5 .58 in TM5 rearrange to fill the resulting gap to extend the hydrogen-bond network towards the E(D)RY motif (pink) and the GaCT peptide (orange). 6.40 ), of which many are conserved in rhodopsin-class GPCRs. The Glu 113 Gln/GaCT structure indicates a rearrangement of this water cluster through rotation of TM6. The water-mediated link between Trp 265 6.48 in TM6 and Ser 298 7.45 in TM7 is broken, whereas Ser 298 7.45 , together with water molecule 16, Asn 55 1.50 , Asp 83 2.50 and Asn 302 7.49 , continues to stabilize the unusual Pro kink introduced in TM7 28 by Pro 303 7.50 . These reorganizations are comparatively minor, but they directly link changes in the CWXP motif in the retinal-binding pocket with the two most conserved residues in TM1 and TM2, and the NPXXY motif in TM7. On the cytoplasmic side, the rotation of TM6 opens the hydrophobic barrier, allowing We have described how translocation of the retinal b-ionone ring can lead to the conformational changes that allow rhodopsin to bind its G protein (Fig. 4) . In doing so, we show how an agonist is bound to the active state of a GPCR and how activation is accompanied by a reorganization of hydrogen-bond networks between some of the most conserved residues among GPCRs.
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network found in ground-state rhodopsin that begins at Trp 265 6.
METHODS SUMMARY
We cloned and expressed the rhodopsin gene containing the stabilizing Asn 2 Cys/ Asp 282 Cys and Glu 113 Gln counterion mutations in HEK293S cells with restricted and homogenous N-glycosylation 30 . The receptor was purified using a 1D4 immunoaffinity matrix and reconstituted with 11-cis retinal under dim red light as previously described 17 . Just before crystallization, we mixed purified rhodopsin with an equal weight of brain lipid extract, 10 mM all-trans retinal and a tenfold molar excess of the GaCT/Lys 341 Leu peptide (ILENLKDCGLF). Rhodopsin was light-activated using a .515-nm long-pass filter to prevent exposure of free retinal and metarhodopsin II. The sample was mixed with an equal volume of 3.0-3.4 M ammonium sulphate, 100 mM sodium acetate, pH 4.5, and crystallized by vapour diffusion in the dark. We collected crystals under dim red light and soaked them in crystallization buffer containing 10% trehalose before freezing them. Diffraction data were collected at synchrotron X-ray sources (the Swiss Light Source, the European Synchrotron Radiation Facility and the Diamond Light Source), integrated using XDS and brought onto a common scale using SCALA. We obtained phases by molecular replacement with the opsin structures (PDB IDs, 3CAP 1 and 3DQB
2 ) or ground-state rhodopsin (PDB ID, 1GZM 6 ) as search model. The resulting solution was refined using iterative cycles of model building in COOT and refinement with PHENIX. The engineered disulphide bond in the extracellular domain is well isolated from the structural motifs involved in rhodopsin activation, which explains its neutral stabilizing characteristics 14, 16 .
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